▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1924 by analyst upside · 2026-06-27
OPCH
Option Care Health, Inc.
Healthcare · Market Cap $3B · P/E 16.8x
ANALYST PRICE TARGET
+31.0%
implied upside to consensus target
Current Price $21.82
Consensus Target $28.58
Bull Target $39.0
Bear Target $22.0
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
4
Buy
7
Hold
1
Sell
0
52-Week Low $18.01
52-Week High $36.8
YTD Return -32.3%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) 16.8x
Forward P/E 10.6x
EPS (TTM) $1.30
PEG Ratio 1.24
Dividend Yield N/A
Revenue (TTM) $5.7B
Profit Margin 3.6%
52-WEEK RANGE
52-Week Low $18.01
52-Week High $36.8
Current Price $21.82
Bear Target $22.0
Bull Target $39.0
● Now $21.82 ● Target $28.58
TRADING DATA
Avg Volume 3.2M
YTD Return -32.3%
Analyst Count 12
Consensus Buy
Upside to Target +31.0%
Last Updated 2026-06-27

ANALYST SUMMARY

Option Care Health, Inc. (OPCH) is currently trading at $21.82 with a Wall Street consensus price target of $28.58, implying potential upside of 31.0% over the next 12 months. 12 analysts currently cover OPCH, with a consensus rating of Buy - 92% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $39.0, while the most cautious has a target of $22.0.

OPCH operates in the Healthcare sector with a market capitalisation of $3B. The stock is down 32.3% year-to-date and is currently trading near the lower end of its 52-week range of $18.01 – $36.8.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

DOCS +21.7%
Doximity, Inc.
$4B · P/E 20.3x · Buy
MMSI +24.8%
Merit Medical Systems, Inc.
$4B · P/E 30.9x · Buy
HAE +10.2%
Haemonetics Corporation
$4B · P/E 37.9x · Buy
ITGR +3.9%
Integer Holdings Corporation
$3B · P/E 23.3x · Buy
PBH +35.2%
Prestige Consumer Healthcare Inc.
$2B · P/E 12.6x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for OPCH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs ● Initiated
Neutral → Neutral 2026-06-08 Building track record
Morgan Stanley — Reiterated
Overweight → Overweight 2026-05-06 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-05-04 43% win rate (7 calls)
Barrington Research — Reiterated
Outperform → Outperform 2026-05-01 Building track record
UBS — Reiterated
Buy → Buy 2026-05-01 33% win rate (6 calls)
TD Cowen — Reiterated
Hold → Hold 2026-05-01 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-01-16 Building track record
Morgan Stanley — Reiterated
Overweight → Overweight 2026-01-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
56
out of 100
Coverage depth
20/30
Consensus clarity
14/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →